Early Cancer Detection Manufacturers, Suppliers & Companies
-
Technologybased in New York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
Technology for Early Cancer Detection
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per ...
CONTACT SUPPLIER -
Manufacturerbased in Menlo Park, CALIFORNIA (USA)
We are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power ...
Grail Galleri - Multi-cancer Early Detection Test Kit
The earlier that cancer can be found, the higher the chance of successful treatment and survival. Yet, too often cancer goes undetected until it has progressed to an advanced ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Nucleix EpiCheck - Early Stage Lung Cancer Detection Unit
Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research ...
CONTACT SUPPLIER -
Technologybased in Salt Lake City, UTAH (USA)
IONIQ Sciences’ vision is to dramatically improve the cancer landscape with a modern solution at the point-of-care for early detection of multiple cancers thereby expanding the therapeutic window, significantly improving survivability, and reducing ...
-
Manufacturerbased in Seville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
-
Manufacturerbased in Valladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
DiagnoLung - Non-Invasive Early Detection Test Cutting Edge Liquid Biopsy Technology for Lung Cancer
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of individuals with Lung ...
CONTACT SUPPLIER -
Technologybased in Phoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
Model LuCED Test - Lung Cell Evaluation Device
The LuCED test is a non-intrusive sputum sample that we collect from you and then analyze using our Cell-CT machine. From this sample, LuCED is designed to detect lung cancer early by ...
CONTACT SUPPLIER -
Manufacturerbased in Bristol, UNITED KINGDOM
Micrima have developed MARIA®, a radiowave breast detection tool, initially pioneered at the University of Bristol in the UK. Micrima are transforming the detection of breast cancer for all women, making a difference to the early diagnosis of breast ...
MARIA - Breast Cancer Detection Tool
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The ...
CONTACT SUPPLIER -
Manufacturerbased in Amsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
Development Services
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. ...
CONTACT SUPPLIER -
Manufacturerbased in Louisville, KENTUCKY (USA)
Breath Diagnostics, Inc. (“Breath-Dx” or “the Company”), is a medical-device diagnostics company developing a novel, patented breath analysis system to quantify cancer specific markers in exhaled breath. The Company’s proprietary technology, ...
OneBreath Technology
method for lung cancer detection/diagnosis to date. The OneBreath™ test can be done in office-based, and retail (pharmacy/drugstores) settings, enabling greater accessibility to lung cancer ...
CONTACT SUPPLIER -
Technologybased in Jena, GERMANY
As a biotechnology company, we at oncgnostics GmbH have been working on the diagnosis of cancer on a molecular biological basis since 2012. Our cancer tests are used in early cancer detection and diagnosis.Our first product, GynTect®, was developed ...
-
Manufacturerbased in Richmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark - Model SSAT1 - Diagnostics Liquid Biopsy Assay
alert tool, it is valuable to physicians around the world. It is a valuable tool for early stage cancer ...
CONTACT SUPPLIER -
Service providerbased in Nottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Early Detection of Lung Cancer
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most ...
CONTACT SUPPLIER -
Manufacturerbased in Cleveland, OHIO (USA)
Cleveland Diagnostics, Inc. is a commercial-stage diagnostics company developing highly efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. The Company’s Solvent Interaction Analysis ...
IsoPSA - Prostate Biopsy Testing System
IsoPSA Proceed to biopsy only when needed. IsoPSA is now included in NCCN® Prostate Cancer Early Detection Guidelines. IsoPSA can help reduce unnecessary prostate biopsies by up to 55%. Up to ...
CONTACT SUPPLIER -
Manufacturerbased in Rockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
PAULAs - Blood Test - Early Detection of Lung Cancer
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at ...
CONTACT SUPPLIER -
Manufacturerbased in Alpharetta, GEORGIA (US) (USA)
Provista Diagnostics, a medical diagnostics company based in Alpharetta, GA, is simplifying early cancer detection. Provista helps to diagnose diseases and inform better clinical decisions for the enhancement of health and quality of life. As a ...
-
Manufacturerbased in Paris Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
Rarecells ISET - Isolation by SizE of Tumor Cells Technology
ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority ...
CONTACT SUPPLIER -
Service providerbased in Guangzhou, CHINA
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy ...
-
Software vendorbased in San Francisco, CALIFORNIA (USA)
We are building a world where clinical care is data-driven, intelligent and patient-focused. Medicine should be powered by data. Physicians should be empowered with every piece of information they need to make the best possible diagnosis and ...
Arterys - Version Breast AI - The World-Class Solution for Early Detection of Breast Cancer.
Breast AI provides innovative solutions for breast cancer detection, measure breast density and assess personalized risk that offer clinically proven benefits to clinicians and patients, and are designed to ...
CONTACT SUPPLIER -
Manufacturerbased in Huntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you